Evidence map›Paper›PMID 39187977›Full record

ArticleJournal of cachexia, sarcopenia and muscle2024

Betaine delays age-related muscle loss by mitigating Mss51-induced impairment in mitochondrial respiration via Yin Yang1.

Si Chen, Tongtong He, Jiedong Chen, Dongsheng Wen, Chen Wang, Wenge Huang, Zhijun Yang, Mengtao Yang, Mengchu Li, Siyu Huang and 2 more

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Si ChenDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Tongtong HeDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Jiedong ChenDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Dongsheng WenDepartment of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Chen WangDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Wenge HuangCenter of Experimental Animals, Sun Yat-sen University, Guangzhou, China.
Zhijun YangDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Mengtao YangDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Mengchu LiDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Siyu HuangDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Zihui HuangDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Huilian ZhuDepartment of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-5019-2827

Funding

Basic and Applied Basic Research Foundation of Guangdong Province, China 2021A1515110848China Postdoctoral Science Foundation 2022M713556National Natural Science Foundation of China 81773415National Natural Science Youth Foundation of China 82204020
6 · The paper itself

Abstract

backgroundMitochondrial dysfunction is one of the hallmarks of aging and a leading contributor to sarcopenia. Nutrients are essential for improving mitochondrial function and skeletal muscle health during the aging process. Betaine is a nutrient with potential muscle-preserving properties. However, whether and how betaine could regulate the mitochondria function in aging muscle are poorly understood. We aimed to explore the molecular target and underlying mechanism of betaine in attenuating the age-related mitochondrial dysfunction in skeletal muscle.

methodsYoung mice (YOU, 2 months), old mice (OLD, 15 months), and old mice with betaine treatment (BET, 15 months) were fed for 12 weeks. The effects of betaine on muscle mass, strength, function, and subcellular structure of muscle fibres were assessed. RNA sequencing (RNA-seq) was conducted to identify the molecular target of betaine. The impacts of betaine on mitochondrial-related molecules, superoxide accumulation, and oxidative respiration were examined using western blotting (WB), immunofluorescence (IF) and seahorse assay. The underlying mechanism of betaine regulation on the molecular target to maintain mitochondrial function was investigated by luciferase reporter assay, chromatin immunoprecipitation and electrophoretic mobility shift assay. Adenoassociated virus transfection, succinate dehydrogenase staining (SDH), and energy expenditure assessment were performed on 20-month-old mice for validating the mechanism in vivo.

resultsBetaine intervention demonstrated anti-aging effects on the muscle mass (P = 0.017), strength (P = 0.010), and running distance (P = 0.013). Mitochondrial-related markers (ATP5a, Sdha, and Uqcrc2) were 1.1- to 1.5-fold higher in BET than OLD (all P ≤ 0.036) with less wasted mitochondrial vacuoles accumulating in sarcomere. Bioinformatic analysis from RNA-seq displayed pathways related to mitochondrial respiration activity was higher enriched in BET group (NES = -0.87, FDR = 0.10). The quantitative real time PCR (qRT-PCR) revealed betaine significantly reduced the expression of a novel mitochondrial regulator, Mss51 (-24.9%, P = 0.002). In C2C12 cells, betaine restored the Mss51-mediated suppression in mitochondrial respiration proteins (all P ≤ 0.041), attenuated oxygen consumption impairment, and superoxide accumulation (by 20.7%, P = 0.001). Mechanically, betaine attenuated aging-induced repression in Yy1 mRNA expression (BET vs. OLD: 2.06 vs. 1.02, P = 0.009). Yy1 transcriptionally suppressed Mss51 mRNA expression both in vitro and in vivo. This contributed to the preservation of mitochondrial respiration, improvement for energy expenditure (P = 0.008), and delay of muscle loss during aging process.

conclusionsAltogether, betaine transcriptionally represses Mss51 via Yy1, improving age-related mitochondrial respiration in skeletal muscle. These findings suggest betaine holds promise as a dietary supplement to delay skeletal muscle degeneration and improve age-related mitochondrial diseases.

Indexed as

BetaineAgingAnimalsDisease Models, AnimalHumansMaleMiceMitochondriaMuscle, SkeletalSarcopeniaYY1 Transcription FactorBetaineYY1 Transcription FactorBetaineMitochondrial dysfunctionMss51Muscle lossTranscription factorYin yang1 (Yy1)

Identifiers

PMID39187977
PMCPMC11446699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.